Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Despite the current downward trend, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 ...

Non-surgical weight loss treatments are becoming more accessible, effective, and more in tune with your body's natural ...

DEAR PEOPLE’S PHARMACY: I’ve been on Ozempic for several months now ... have also found semaglutide (Ozempic, Wegovy) effective for blood sugar control and weight loss. There are downsides ...

But the popular injection is seeing new competition with Mounjaro, and now a daily pill which could help patients lose 16 ...